Pharma

Apr 17 2018

Board of Directors, Neurocrine Biosciences, biosante pharmaceuticals.#Biosante #pharmaceuticals

Board of Directors Dr. Rastetter, has served on the Board of Directors since February 2010 and as Chairman of the Board of Directors since May 2011. Currently, he serves as the Chairman of the Board of Directors for Fate Therapeutics, a publicly traded company focused on stem cell research. Dr. Rastetter also services on the Board of Directors at Regulus Therapeutics, a publicly traded company focused on RNA based therapeutics and as the Lead Outside Director for Cerulean Pharma, Inc., a private company focused on innovative oncology therapies. Dr. Rastetter was a partner in the venture capital firm, Venrock, from …

Apr 17 2018

Bio-Santee Chem, biosante pharmaceuticals.#Biosante #pharmaceuticals

В Bio-Santee ChemВ В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В В The Key of Success to life В В В В В В В В В В В В В В В В В В В В В В В В В В В …

Feb 13 2018

Board of Directors, Neurocrine Biosciences, biosante pharmaceuticals.#Biosante #pharmaceuticals

Board of Directors Dr. Rastetter, has served on the Board of Directors since February 2010 and as Chairman of the Board of Directors since May 2011. Currently, he serves as the Chairman of the Board of Directors for Fate Therapeutics, a publicly traded company focused on stem cell research. Dr. Rastetter also services on the Board of Directors at Regulus Therapeutics, a publicly traded company focused on RNA based therapeutics and as the Lead Outside Director for Cerulean Pharma, Inc., a private company focused on innovative oncology therapies. Dr. Rastetter was a partner in the venture capital firm, Venrock, from …

Feb 13 2018

Board of Directors, Neurocrine Biosciences, biosante pharmaceuticals.#Biosante #pharmaceuticals

Board of Directors Dr. Rastetter, has served on the Board of Directors since February 2010 and as Chairman of the Board of Directors since May 2011. Currently, he serves as the Chairman of the Board of Directors for Fate Therapeutics, a publicly traded company focused on stem cell research. Dr. Rastetter also services on the Board of Directors at Regulus Therapeutics, a publicly traded company focused on RNA based therapeutics and as the Lead Outside Director for Cerulean Pharma, Inc., a private company focused on innovative oncology therapies. Dr. Rastetter was a partner in the venture capital firm, Venrock, from …